Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Titel:
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Auteur:
Yu, Evan Y Petrylak, Daniel P O'Donnell, Peter H Lee, Jae-Lyun van der Heijden, Michiel S Loriot, Yohann Stein, Mark N Necchi, Andrea Kojima, Takahiro Harrison, Michael R Hoon Park, Se Quinn, David I Heath, Elisabeth I Rosenberg, Jonathan E Steinberg, Joyce Liang, Shang-Ying Trowbridge, Janet Campbell, Mary McGregor, Bradley Balar, Arjun V